CN1628836A - Chinese patent drug for treating leucoderma - Google Patents

Chinese patent drug for treating leucoderma Download PDF

Info

Publication number
CN1628836A
CN1628836A CN 200410075351 CN200410075351A CN1628836A CN 1628836 A CN1628836 A CN 1628836A CN 200410075351 CN200410075351 CN 200410075351 CN 200410075351 A CN200410075351 A CN 200410075351A CN 1628836 A CN1628836 A CN 1628836A
Authority
CN
China
Prior art keywords
radix
parts
fructus
powder
chinese patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410075351
Other languages
Chinese (zh)
Inventor
王俊伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410075351 priority Critical patent/CN1628836A/en
Publication of CN1628836A publication Critical patent/CN1628836A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a Chinese patent drug for treating leucoderma and the method for preparing the medicament comprises, using fourteen Chinese medicinal herbs including Vernonia amygdalina Del., puncturevine, white moss bark as raw material, carrying out low-temperature disintegrating, solvent extracting, concentration preliminary treatment, ripening and sterilizing. The medicament is made into the dosage form of powder, pill and capsule.

Description

The leukodermic Chinese patent medicine of a kind of treatment
The leukodermic Chinese patent medicine of a kind of treatment of the present invention relates to pharmaceutical field, it specifically is raw material with the Chinese herbal medicine, particularly with Caulis Vernoniae andersonii, Fructus Tribuli be that main warp is pulverized, solvent extracts, concentrate, vitiligo combination drug that technical matters such as sterilization is prepared from, effect is obvious.The invention still further relates to the preparation method of this combination drug.
Vitiligo is a kind of chronic non-infectious depigmentation common skin diseases, good sending out in each age group, because the cause of disease is not fully aware of, also there is not at present a kind of lasting specific treatment medicine, but the medical science sages of the past have utilized difficult disease such as Chinese medicine combination of inner and outside treatment vitiligo, obtain better curative effect.Though non-life threatening of vitiligo dailyly causes greatly with psychological pressure mentally to the patient, having a strong impact on work, study and social communication.According to statistics, China's vitiligo sickness rate accounts for dermopathic 0.54%-1.03%; External report shows: U.S.'s vitiligo prevalence accounts for 1%, and Denmark accounts for 0.46%, and the India Surat accounts for 1.13%, and Calcutta accounts for 0.46%, and the French West Indies is reported as about 0.5%-1%.Fructus Pruni woods elite tackling key problem is hand in hand appealed by international community, breaks through the difficult disease treatment that comprises vitiligo early.
Medical circle generally acknowledges that the leukodermic cause of disease is because the hypofunction or the forfeiture of the interior tryrosinase system of the melanocyte of skin and hair follicle cause.Onset state is with area, ethnic group and difference, and the dark more sickness rate of general colour is then high more.The leukodermic factors such as heredity, spirit nerve, chemistry, autoimmune, endocrine, low copper, infection that betide also have close ties.It is considered herein that immunologic derangement and endocrine disturbance are the key factors that vitiligo takes place, under normal circumstances, the skin melanocyte is present in skin and the intrafollicular melanocyte, tyrosine in the melanocyte is oxidized to DOPA under the effect of tryrosinase, through a series of biochemical metabolism process, generating melanocyte needs for body again.Anyly cause the organism metabolism functional disorder or influence the synthetic factor of melanocyte, can cause all that melanin generates reduces or disappears, and skin depigmentation occurs, and its result will show as leukoderma, i.e. vitiligo.
Medicine of the present invention belongs to the traditional medicine category.Motherland's medical science is that international community generally acknowledges to the therapeutic effect of chronic disease, and " acute disease sees a doctor trained in western medicine, slow disease is registered the department of Chinese medicine " become idea sanctified by usage of hospitalier.Because Chinese medicine contains multiple active ingredient, can tackle a plurality of curative drug action target spots, solve the insoluble problem of doctor trained in Western medicine, multiple components is passed through reparation, replacement or the intervention to gene, and breakthrough treatment endocrine regulation disease is satisfactory for result, Chinese medicinal ingredients is active strong, the curative effect height, toxic and side effects is little, is beneficial to the persistence medication after treatment of chronic disease.
The present invention treats Caulis Vernoniae andersonii in the leukodermic Chinese patent medicine prescription, wind dispelling, dampness are arranged, relax through, invigorate blood circulation, effect such as blood stasis dispelling, compatibility Flos Carthami, Radix Salviae Miltiorrhizae etc. can improve local microcirculation, improve photosensitization; Add QI invigorating such as Fructus Psoraleae, the Radix Polygoni Multiflori, Semen Sesami Nigrum, the Radix Astragali and keep fit two accent immunologic functions, trace element supplement; After all medicines are comprehensive, make its synergism of bringing into play each medicine, strengthen the activity of tryrosinase, promote the synthetic of dermal melanin cell, correct the tricarboxylic acid cycle system of biochemical metabolism, thus effective to the skin depigmentation disease.
Another purpose that the present invention treats the vitiligo Chinese patent medicine provides a kind of preparation method of this medicine.It is characterized in that the formula Chinese drug raw material is abided by after Gu concocts into the prepared slices of Chinese crude drugs; It is standby to choose Caulis Vernoniae andersonii, the Radix Astragali, Semen Sesami Nigrum, Fructus Fici, Radix Salviae Miltiorrhizae, the Radix Angelicae Dahuricae, Fructus Psoraleae, Flos Carthami eight flavor pulverize at low temperature to 120 mesh sieve fine powders; With Cortex Dictamni, Fructus Tribuli, the Radix Polygoni Multiflori, Herba Ecliptae, Radix Arnebiae (Radix Lithospermi), the Poria Six-element is cataclasm, water decocts secondary, 3 hours for the first time, 2 hours for the second time, filter, discard residue, collecting decoction, filtrate is condensed into thick paste; Mix with standby fine powder, drying is ground into impalpable powder, and mixing carries out ripening, sterilization treatment 20-30 minute under 100 ℃ of-110 ℃ of temperature, make powder; With the powder water pill, freeze-day with constant temperature is used the Pulvis Talci coating, and polishing makes pill; Powder is filled with the Capsules shell, and grain is picked up in polishing, makes capsule.
The present invention treats leukodermic Chinese patent medicine medicine, based on more than, in conjunction with clinical nearly hundred examples for many years the use of patients with vitiligo is observed, total effective rate reaches more than 94%, if with the topical agent associating, effect is better.So vitiligo new Chinese medicine of the present invention is the effective agent of a kind of worth exploitation, popularization, raising vitiligo cure rate really, and is significant, has a extensive future.

Claims (4)

1, the leukodermic Chinese patent medicine of a kind of treatment is characterized in that it is the medicament of being made by following proportioning raw materials:
Caulis Vernoniae andersonii 10-30 part Fructus Tribuli 10-30 part Cortex Dictamni 10-20 part
Radix Arnebiae (Radix Lithospermi) 10-25 part Radix Polygoni Multiflori 10-20 part Fructus Psoraleae 10-20 part
Poria 10-20 part Flos Carthami 10-20 part Semen Sesami Nigrum 10-20 part
Radix Astragali 10-20 part Radix Salviae Miltiorrhizae 10-20 part Radix Angelicae Dahuricae 10-20 part
Fructus Fici 10-15 part Herba Ecliptae 10-15 part;
2, treatment vitiligo Chinese patent medicine according to claim 1 is characterized in that the weight proportion of each raw material is:
25 parts of 25 portions of Radix Arnebiae (Radix Lithospermi)s of 30 parts of Cortex Dictamnis of 30 portions of Fructus Tribulis of Caulis Vernoniae andersonii
20 parts on 20 parts of Flos Carthamis of 20 parts of Fructus Psoraleaes of 20 parts of Poria of the Radix Polygoni Multiflori
20 parts of 20 parts of Radixs Angelicae Dahuricae of 20 portions of Semen Sesami Nigrums of 20 parts of Radix Salviae Miltiorrhizaes of the Radix Astragali
10 parts of 10 portions of Herba Ecliptaes of Fructus Fici.
3, treatment vitiligo Chinese patent medicine according to claim 1 and 2 is characterized in that said medicament is powder, pill and capsule.
4, according to the preparation method of claim 1 or 2 or 3 described treatment vitiligo Chinese patent medicines, it is characterized in that earlier the formula Chinese drug raw material being abided by Gu concocts into the prepared slices of Chinese crude drugs after; Caulis Vernoniae andersonii, the Radix Astragali, Semen Sesami Nigrum, Fructus Fici, Radix Salviae Miltiorrhizae, the Radix Angelicae Dahuricae, Fructus Psoraleae, Flos Carthami eight flavor pulverize at low temperature to 120 mesh sieve fine powders are standby; With Cortex Dictamni, Fructus Tribuli, the Radix Polygoni Multiflori, Herba Ecliptae, Radix Arnebiae (Radix Lithospermi), the Poria Six-element is cataclasm, water decocts secondary, 3 hours for the first time, 2 hours for the second time, filter, discard residue, collecting decoction, filtrate is condensed into thick paste; Mix with standby fine powder, drying is ground into impalpable powder, and mixing carries out ripening, sterilization treatment 20-30 minute under 100 ℃ of-110 ℃ of temperature, make powder; With the powder water pill, freeze-day with constant temperature is used the Pulvis Talci coating, and polishing makes pill; Powder is filled with the Capsules shell, and grain is picked up in polishing, makes capsule.
CN 200410075351 2004-08-23 2004-08-23 Chinese patent drug for treating leucoderma Pending CN1628836A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410075351 CN1628836A (en) 2004-08-23 2004-08-23 Chinese patent drug for treating leucoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410075351 CN1628836A (en) 2004-08-23 2004-08-23 Chinese patent drug for treating leucoderma

Publications (1)

Publication Number Publication Date
CN1628836A true CN1628836A (en) 2005-06-22

Family

ID=34846928

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410075351 Pending CN1628836A (en) 2004-08-23 2004-08-23 Chinese patent drug for treating leucoderma

Country Status (1)

Country Link
CN (1) CN1628836A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101461847B (en) * 2009-01-13 2011-03-23 牛付立 Medicament composition for treating leukoderma
CN103948684A (en) * 2014-04-15 2014-07-30 郎溪县志瑞企业信息服务有限公司 Externally-applied liniment for treating leucoderma
CN104147147A (en) * 2013-12-17 2014-11-19 河南茗轩食品科技有限公司 Traditional Chinese medicinal composition for treating skin diseases and preparation method thereof
CN106421717A (en) * 2016-11-26 2017-02-22 新疆维吾尔自治区维吾尔医药研究所 Uighur medicine compound effective parts and effective part group for treating leucoderma and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101461847B (en) * 2009-01-13 2011-03-23 牛付立 Medicament composition for treating leukoderma
CN104147147A (en) * 2013-12-17 2014-11-19 河南茗轩食品科技有限公司 Traditional Chinese medicinal composition for treating skin diseases and preparation method thereof
CN104147147B (en) * 2013-12-17 2016-07-06 河南茗轩食品科技有限公司 One is used for treating dermopathic Chinese medicine composition and preparation method
CN103948684A (en) * 2014-04-15 2014-07-30 郎溪县志瑞企业信息服务有限公司 Externally-applied liniment for treating leucoderma
CN103948684B (en) * 2014-04-15 2016-06-15 郎溪县志瑞企业信息服务有限公司 A kind of outer liniment being used for the treatment of vitiligo
CN106421717A (en) * 2016-11-26 2017-02-22 新疆维吾尔自治区维吾尔医药研究所 Uighur medicine compound effective parts and effective part group for treating leucoderma and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100382839C (en) Chinese-medicinal composition for treating coronary heart disease
CN101732683A (en) Chinese medicinal preparation for treating facial chloasma and preparation method thereof
CN103566350A (en) Pharmaceutical composition having blood sugar reducing effect
CN102552454A (en) Traditional Chinese medicine for curing diabetic foot
CN101049340A (en) A pharmaceutical composition for treating vitiligo and its preparation method
CN101391047B (en) Traditional Chinese medicine preparation for treating trichonosis
CN101249175A (en) Chinese medicine prescription for curing myopic eye disease and production method of preparations
CN101584759A (en) Pharmaceutical composition with pure plant origin and application thereof
CN100386106C (en) Medicine for treating acne and its preparation
CN1628836A (en) Chinese patent drug for treating leucoderma
CN102204978B (en) Medicinal composition for treating cancer pain and preparation thereof
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN102100849B (en) Chinese medicine preparation for treating lumbar disc herniation and preparation method thereof
CN110141622B (en) Traditional Chinese medicine composition for treating pain and preparation method and application thereof
CN103520684B (en) Traditional Chinese medicine compound for reducing blood sugar
CN101229224B (en) Chinese traditional medicine ointment preparation for curing vitligo and preparing method thereof
CN105963201A (en) Medicinal and edible sugar reducing toothpaste and preparation method thereof
CN101336990B (en) Medicine for treating cholecystitis
CN104547619A (en) Traditional Chinese medicine for treating apoplexy sequela paralytic limbs and preparation method of traditional Chinese medicine
CN102908508B (en) Medicinal composition for treating seborrheic alopecia and preparation method thereof
CN1308024C (en) Medicine for treating diabetes and its preparing method
CN110141621B (en) Traditional Chinese medicine composition for treating pain and preparation method and application thereof
CN102370838B (en) Kidney-invigorating and tendon-reinforcing double-phase capsule
CN101612233B (en) Chinese medicine preparation for detumescence and analgesia
CN106581445A (en) Traditional Chinese medicine prescription for treating diabetic retinopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication